| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA687640 | F | Cytotoxic dose required to reduce the viability of normal uninfected MT-4 cells. | Homo sapiens | 29 | cell-based format | Scientific Literature | ||
| 2. | ALA694656 | F | Tested in vitro against MT-4 cells using MTT assay | Homo sapiens | 21 | cell-based format | Scientific Literature | ||
| 3. | ALA698918 | F | Cytotoxic dose required to inhibit HIV-induced cytopathogenicity in human MT-4 cells | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 4. | ALA696399 | F | Effective dose required to inhibit HIV-induced cytopathogenicity in human MT-4 cells | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 5. | ALA697216 | F | Concentration required to reduce the viability of Human T-lymphoblast MT-4 cells | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 6. | ALA712341 | F | Effective concentration to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1 | 28 | cell-based format | Scientific Literature | |||
| 7. | ALA712342 | F | Effective concentration to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-2 | 28 | cell-based format | Scientific Literature | |||
| 8. | ALA879738 | F | Effective concentration of compound required to reduce the cytopathic effect of HIV-1 IIIB in MT-4 cells by 50% | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
| 9. | ALA712343 | F | Effective concentration of compound required to reduce the cytopathic effect of HIV-2ROD in MT-4 cells by 50% | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
| 10. | ALA712345 | F | Effective concentration required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1 | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
| 11. | ALA712347 | F | Effective concentration required to inhibit HIV-1-induced cytopathicity in MT-4 cells | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 12. | ALA712352 | F | In vitro inhibition of cytopathic effect was determined against HIV-1 IIIB in MT-4 cells using MTS cytoprotection assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 13. | ALA712353 | F | Inhibition of HIV-1 (strain A17)-infected MT-4 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 14. | ALA712354 | F | Inhibition of cytopathic effect of HIV-1 in MT-4 cells | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
| 15. | ALA712355 | F | Inhibition of cytopathic effect of HIV-1 strain RF in MT-4 cell culture | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 16. | ALA712356 | F | Inhibition of cytopathic effect of HIV-1 strain RF in MT-4 cell culture | 34 | cell-based format | Scientific Literature | |||
| 17. | ALA712358 | F | Inhibitory activity against HIV-1 IIIB in MT-4 infected cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 18. | ALA712359 | F | Inhibitory activity toward HIV replication in MT-4 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 19. | ALA879739 | F | Tested for cytotoxic concentration required to reduce the viability of MT-4 cells by 50% | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 20. | ALA884419 | F | Tested for effective concentration required to protect MT-4 cells against the cytopathicity of HIV-1(IIIB) | Homo sapiens | 1 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!